ACTIVE_NOT_RECRUITING

Health-Related Physical Fitness Level From Smartwatches

Conditions

Exercise Capacity Flexibility Strength and Endurance

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Health-related physical fitness (HRPF) has demonstrated high clinical relevance, and its level is associated with the ability to perform activities of daily living with vigor and a lower risk of chronic disease. Consequently, exercise prescription guidelines recommend improving HRPF as a focus for prevention and rehabilitation programs. Measuring and tracking HRPF often requires specialized equipment and personnel, which are expensive and less applicable to the general population. Wearables may mitigate this issue by providing useful estimates of the HRPF.

Official Title

Health-Related Physical Fitness Level From Smartwatches

Quick Facts

Study Start:2025-01-01

Study Completion:2025-12-25

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06805422

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 60 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* 20-60 years old * actively training or competing over the past 2 years * 3 or more days of vigorous activity accumulating approximately least 1500 MET min/week or 7 days of any combination of walking, moderate, or vigorous intense activities achieving a minimum of 3000 MET min/week * 20-60 years old * actively training or competing over the past 2 years * 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10 * 20-60 years old * actively training or competing over the past 2 years * 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10 * 20-60 years old * Sit-and-reach performance is categorized as "very good" or excellent based on the American College of Sports Medicine's sit-and-reach evaluation criteria (Table 4.16 of ACSM's Guidelines for Exercise Testing and Prescription 9th edition).	* History of cardiovascular disease (Cardiac, peripheral vascular, or cerebrovascular disease) * History of stable or unstable angina * History of cardiac dysrhythmias causing symptoms or hemodynamic consequences * History of hypertrophic cardiomyopathy * History of cardiac valvular disease (e.g., aortic stenosis) * History of pulmonary disease (Chronic obstructive pulmonary disease, asthma, interstitial lung disease, or cystic fibrosis) * History of pulmonary embolus * History of suspected or known aneurysm * History of metabolic disease (Diabetes mellitus (type I or II), thyroid disorders, renal or liver disease * History of renal disease * History of neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise * Current acute systemic infection, accompanied by fever and body aches. * Pain or discomfort in the chest, neck, jaw, arms, or other areas that may be due to myocardial ischemia (lack of adequate circulation) * Shortness of breath at rest, during daily activities, or with mild exertion * Dizziness or syncope (fainting) * Orthopnea (breathing discomfort when not in an upright position) or paroxysmal nocturnal dyspnea (interrupted breathing at night) * Ankle edema (swelling) * Palpitations (abnormal rapid beating of the heart) or tachycardia (rapid heartbeat) * Intermittent claudication (cramping pain and weakness in legs, especially calves, during walking due to inadequate blood supply to muscles) * Known heart murmur (atypical heart sound indicating a structural or functional abnormality) * Unusual or unexplained fatigue * Severe arterial hypertension (i.e., systolic blood pressure of \>200 mm Hg and/or a diastolic blood pressure of \>110 mm Hg) at rest.

Inclusion Criteria

Exclusion Criteria

* 20-60 years old
* actively training or competing over the past 2 years
* 3 or more days of vigorous activity accumulating approximately least 1500 MET min/week or 7 days of any combination of walking, moderate, or vigorous intense activities achieving a minimum of 3000 MET min/week
* 20-60 years old
* actively training or competing over the past 2 years
* 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
* 20-60 years old
* actively training or competing over the past 2 years
* 3 or more days of muscle-strengthening exercise at an intensity of approximately 5 out of 10
* 20-60 years old
* Sit-and-reach performance is categorized as "very good" or excellent based on the American College of Sports Medicine's sit-and-reach evaluation criteria (Table 4.16 of ACSM's Guidelines for Exercise Testing and Prescription 9th edition).

* History of cardiovascular disease (Cardiac, peripheral vascular, or cerebrovascular disease)
* History of stable or unstable angina
* History of cardiac dysrhythmias causing symptoms or hemodynamic consequences
* History of hypertrophic cardiomyopathy
* History of cardiac valvular disease (e.g., aortic stenosis)
* History of pulmonary disease (Chronic obstructive pulmonary disease, asthma, interstitial lung disease, or cystic fibrosis)
* History of pulmonary embolus
* History of suspected or known aneurysm
* History of metabolic disease (Diabetes mellitus (type I or II), thyroid disorders, renal or liver disease
* History of renal disease
* History of neuromotor, musculoskeletal, or rheumatoid disorders that are exacerbated by exercise
* Current acute systemic infection, accompanied by fever and body aches.
* Pain or discomfort in the chest, neck, jaw, arms, or other areas that may be due to myocardial ischemia (lack of adequate circulation)
* Shortness of breath at rest, during daily activities, or with mild exertion
* Dizziness or syncope (fainting)
* Orthopnea (breathing discomfort when not in an upright position) or paroxysmal nocturnal dyspnea (interrupted breathing at night)
* Ankle edema (swelling)
* Palpitations (abnormal rapid beating of the heart) or tachycardia (rapid heartbeat)
* Intermittent claudication (cramping pain and weakness in legs, especially calves, during walking due to inadequate blood supply to muscles)
* Known heart murmur (atypical heart sound indicating a structural or functional abnormality)
* Unusual or unexplained fatigue
* Severe arterial hypertension (i.e., systolic blood pressure of \>200 mm Hg and/or a diastolic blood pressure of \>110 mm Hg) at rest.

Contacts and Locations

Study Locations (Sites)

Kansas State Univeristy

Manhattan, Kansas, 66506

United States

Collaborators and Investigators

Sponsor: Kansas State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-01

Study Completion Date2025-12-25

Study Record Updates

Study Start Date2025-01-01

Study Completion Date2025-12-25

Terms related to this study

Additional Relevant MeSH Terms

Exercise Capacity
Flexibility
Strength and Endurance